IntrinsicIntrinsic
← Scroll for more →

Financial Statements — STHO

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
Cash & Equivalents52.8162.0650.0840.5944.2030.3134.9645.0548.2845.7350.6645.5654.9470.24
Total Assets508.22480.36570.20595.86589.92618.24608.66696.54601.04622.91669.20604.27702.39813.12
Long-term Debt208.84207.00268.72259.27245.40231.46217.35201.21197.21195.02192.90212.82227.40251.78
Total Liabilities225.24240.20304.33302.20293.97281.87263.66247.92244.29238.20235.36255.49271.71292.49
Retained Earnings(316.25)(357.70)(347.44)(328.31)(330.11)(290.80)(283.20)(180.64)(272.54)(245.42)(196.44)(262.57)(180.76)(90.80)
Total Stockholder Equity281.72238.89251.77275.43276.14316.14324.34427.55335.32362.42411.55344.92426.88516.84
← Scroll for more columns →

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
Total Revenue19.3620.9425.3628.1142.0514.6232.7624.5530.5525.4437.2243.5725.4816.79
Interest Expense--------------------------10.10
Net Income41.45(10.26)(19.14)1.80(39.31)(7.60)(102.56)91.90(27.11)(48.98)66.13(81.81)(89.96)(90.71)
Diluted EPS3.43(0.85)(1.52)0.14(2.95)(0.57)(7.69)6.90(2.04)(3.68)4.96(6.14)(6.75)(6.81)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
Operating Cash Flow(2.83)(8.40)(8.00)5.31(2.64)(6.33)(6.87)(3.79)(6.41)(14.23)(5.74)(8.32)(4.10)(0.55)
Investing Cash Flow(6.42)0.6316.77(13.91)3.87(8.28)(16.16)(1.04)7.889.6340.1417.0012.10116.78
Financing Cash Flow-0.002.662.638.4911.6212.0914.031.78----(24.90)(15.26)(25.64)(48.27)
← Scroll for more columns →